We investigated the efficacy of dutasteride add‐on therapy to α‐1 adrenoceptor antagonists in patients with benign prostate hyperplasia (BPH) in relation to the transitional zone index (TZI) and evaluated the… Click to show full abstract
We investigated the efficacy of dutasteride add‐on therapy to α‐1 adrenoceptor antagonists in patients with benign prostate hyperplasia (BPH) in relation to the transitional zone index (TZI) and evaluated the cutoff value of TZI that predicted improvements of subjective symptoms at 6 months.
               
Click one of the above tabs to view related content.